Dendreon Set To Release Results Of Prostate Cancer Drug Provenge
April 28, 2009
Boston (dbTechno) - Dendreon is set to release results on their prostate cancer drug Provenge today, and by doing so could make history.
The biotech company based in Seattle will reveal to the world detailed results on what is known as the IMPACT study.
The IMPACT study is set to be presented at the American Urological Association in Chicago at 2:20 p.m. Central time today.
Dendreon revealed a tidbit of information back on April 14th about the drug, stating that the drug was able to increase survival for prostate cancer patients.
Keywords such as the drug being a “clear hit” on the April 14th announcement sent the stock tripling.
Experts believe that if the prostate cancer drug is approved, annual sales would top $1 billion.
We will have more details on this monumental drug later today when all is revealed.
Breaking News
Shawn Thornton Batters Matt Cooke SenselessIt was only a matter of time before the Boston Bruins played the Pittsburgh Penguins, allowing for a little payback to be...
Fess Parker, AKA Davy Crockett Dies at 85Boston (DbTechNo) - It is being reported that Fess Parker, star of Davy Crockett has died at the age of 85. According to...
Joslyn James Releases Racy Texts Sent to Her by Tiger WoodsBoston (DbTechNo) - Just when Tiger Woods appears to be getting his life back on track, another mistress comes crawling...
Comments
All comments are moderated.
If your comment is approved, it will be posted within 24 hours